Abiopharma

Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator

Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors

Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call

The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program

Anika Reports Third Quarter 2025 Financial Results